Get the Stockscreener App
0.0001
50.00%
-0.0001
Canopus BioPharma Incorporated Stock (CBIA) Forecast
The Canopus BioPharma Incorporated (CBIA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.3812, representing a +381.05K% increase from the current price of $0.0001. The highest analyst price target is $0.4117, and the lowest is $0.3506.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CBIA Price Target
Average 0.5636
(+563.49K% Upside)
Long-term CBIA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Canopus BioPharma Incorporated financial reports and earnings history, Canopus BioPharma Incorporated (CBIA) stock could reach $2.0436 by 2030, $4.99 by 2040 and $7.9364 by 2050. See the projected annual prices until 2050 of the Canopus BioPharma Incorporated stock below:
- Canopus BioPharma Incorporated (CBIA) is expected to reach an average price of $3.3286 in 2035, with a high prediction of $3.5168 and a low estimate of $1.9557. This indicates an $3.33M% rise from the last recorded price of $0.0001.
- Canopus BioPharma Incorporated (CBIA) stock is projected to chart a bullish course in 2040, with an average price target of $4.7094, representing an $4.71M% surge from its current level. The forecast ranges from a conservative $2.7821 to a sky-high $4.99.
- Our analysts predict Canopus BioPharma Incorporated (CBIA) to jump 6.09M% by 2045, soaring from $3.6086 to an average price of $6.0902, potentially reaching $6.4632. While $3.6086 is the low estimate, the potential upside is significant.
- Canopus BioPharma Incorporated (CBIA) stock is expected to climb by 2050, reaching an average of $7.471, a $7.47M% jump from its current level. However, a wide range of estimates exists, with high and low targets of $7.9364 and $4.435, respectively, highlighting the market's uncertainty.
Canopus BioPharma Incorporated Stock (CBIA) Year by Year Forecast
Canopus BioPharma Incorporated Stock (CBIA) Price Forecast for 2024
Our forecast for CBIA stock price in 2024 now indicates an average price target of $0.3399 with a high forecast of $0.5196 and a low forecast of $0.1603. The average prediction reflects an increase of +339.84K% from the last recorded price of $0.0001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $0.3506 | $0.3506 | $0.4117 | +350.53K% |
Canopus BioPharma Incorporated Stock (CBIA) Price Forecast for 2025
Canopus BioPharma Incorporated Stock (CBIA) is expected to reach an average price of $0.5636 in 2025, with a high prediction of $0.8244 and a low estimate of $0.3028. This indicates an +563.49K% rise from the last recorded price of $0.0001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.4776 | $0.3028 | $0.5704 | +477.46K% |
| February, 2025 | $0.3823 | $0.3823 | $0.4497 | +382.22K% |
| March, 2025 | $0.6146 | $0.3313 | $0.6212 | +614.50K% |
| April, 2025 | $0.4432 | $0.4432 | $0.522 | +443.08K% |
| May, 2025 | $0.6622 | $0.3598 | $0.672 | +662.11K% |
| June, 2025 | $0.4781 | $0.4781 | $0.5664 | +477.95K% |
| July, 2025 | $0.7228 | $0.3883 | $0.7228 | +722.70K% |
| August, 2025 | $0.5129 | $0.5129 | $0.6818 | +512.82K% |
| September, 2025 | $0.7736 | $0.4168 | $0.7736 | +773.50K% |
| October, 2025 | $0.5478 | $0.5478 | $0.7294 | +547.69K% |
| November, 2025 | $0.8244 | $0.4453 | $0.8244 | +824.30K% |
| December, 2025 | $0.64 | $0.64 | $0.7771 | +639.91K% |
Canopus BioPharma Incorporated Stock (CBIA) Price Forecast for 2026
The predicted value for Canopus BioPharma Incorporated (CBIA) in 2026 is set at an average of $0.8015. Estimates vary from a peak of $1.1292 to a trough of $0.4738, indicating an +801.38K% surge from the present price of $0.0001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.8752 | $0.4738 | $0.8752 | +875.10K% |
| February, 2026 | $0.6781 | $0.6781 | $0.8247 | +677.97K% |
| March, 2026 | $0.5599 | $0.5023 | $0.6175 | +559.80K% |
| April, 2026 | $0.7248 | $0.7368 | $0.926 | +724.74K% |
| May, 2026 | $0.6234 | $0.5308 | $0.7161 | +623.34K% |
| June, 2026 | $0.7661 | $0.7781 | $0.9768 | +765.98K% |
| July, 2026 | $0.6567 | $0.5593 | $0.7542 | +656.62K% |
| August, 2026 | $0.8073 | $0.8193 | $1.0276 | +807.23K% |
| September, 2026 | $0.5878 | $0.5878 | $0.7922 | +587.66K% |
| October, 2026 | $0.8486 | $0.8606 | $1.0784 | +848.47K% |
| November, 2026 | $0.6163 | $0.6163 | $0.8303 | +616.16K% |
| December, 2026 | $0.9663 | $0.9783 | $1.1292 | +966.17K% |
Canopus BioPharma Incorporated Stock (CBIA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Canopus BioPharma Incorporated (CBIA) is $1.0394, with a high forecast of $1.434 and a low forecast of $0.6448. This indicates an +1.04M% increase from the last price of $0.0001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.6448 | $0.6448 | $0.8898 | +644.66K% |
| February, 2027 | $1.0107 | $1.0227 | $1.18 | +1.01M% |
| March, 2027 | $0.7625 | $0.7625 | $0.9311 | +762.43K% |
| April, 2027 | $1.0551 | $0.6733 | $1.2308 | +1.06M% |
| May, 2027 | $0.7942 | $0.7942 | $0.9723 | +794.11K% |
| June, 2027 | $1.2336 | $0.7018 | $1.2816 | +1.23M% |
| July, 2027 | $0.8259 | $0.8259 | $1.0996 | +825.80K% |
| August, 2027 | $1.2812 | $0.7303 | $1.3324 | +1.28M% |
| September, 2027 | $0.9314 | $0.9314 | $1.144 | +931.26K% |
| October, 2027 | $1.3288 | $0.7587 | $1.3832 | +1.33M% |
| November, 2027 | $0.9662 | $0.9662 | $1.1884 | +966.13K% |
| December, 2027 | $1.3764 | $0.7872 | $1.434 | +1.38M% |
Canopus BioPharma Incorporated Stock (CBIA) Price Forecast for 2028
In 2028, Canopus BioPharma Incorporated (CBIA) is projected to reach an average price of $1.2519, with a high projection of $1.688 and a low estimate of $0.8157. This indicates an +1.25M% rise from the last price of $0.0001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.0011 | $1.0011 | $1.2328 | +1.00M% |
| February, 2028 | $1.4848 | $0.8157 | $1.4848 | +1.48M% |
| March, 2028 | $1.036 | $1.036 | $1.396 | +1.04M% |
| April, 2028 | $1.5356 | $0.8442 | $1.5356 | +1.54M% |
| May, 2028 | $1.1728 | $1.1728 | $1.4436 | +1.17M% |
| June, 2028 | $1.5864 | $0.8727 | $1.5864 | +1.59M% |
| July, 2028 | $1.2109 | $1.2109 | $1.4913 | +1.21M% |
| August, 2028 | $1.0035 | $0.9012 | $1.1057 | +1.00M% |
| September, 2028 | $1.2489 | $1.2489 | $1.6372 | +1.25M% |
| October, 2028 | $1.0352 | $0.9297 | $1.1406 | +1.04M% |
| November, 2028 | $1.3435 | $1.3555 | $1.688 | +1.34M% |
| December, 2028 | $1.1226 | $0.9582 | $1.287 | +1.12M% |
Canopus BioPharma Incorporated Stock (CBIA) Price Forecast for 2029
The 2029 price forecast for Canopus BioPharma Incorporated Stock (CBIA) is $1.4898 on average, with a high prediction of $1.9928 and a low estimate of $0.9867. This represents an +1.49M% increase from the previous price of $0.0001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.3847 | $1.3967 | $1.7388 | +1.38M% |
| February, 2029 | $0.9867 | $0.9867 | $1.325 | +986.63K% |
| March, 2029 | $1.426 | $1.438 | $1.7896 | +1.43M% |
| April, 2029 | $1.0152 | $1.0152 | $1.3631 | +1.02M% |
| May, 2029 | $1.5883 | $1.6003 | $1.8404 | +1.59M% |
| June, 2029 | $1.0437 | $1.0437 | $1.4672 | +1.04M% |
| July, 2029 | $1.6327 | $1.6447 | $1.8912 | +1.63M% |
| August, 2029 | $1.0722 | $1.0722 | $1.5084 | +1.07M% |
| September, 2029 | $1.6771 | $1.6891 | $1.942 | +1.68M% |
| October, 2029 | $1.2378 | $1.2378 | $1.5497 | +1.24M% |
| November, 2029 | $1.7216 | $1.1007 | $1.9928 | +1.72M% |
| December, 2029 | $1.2695 | $1.2695 | $1.5909 | +1.27M% |
Canopus BioPharma Incorporated Stock (CBIA) Price Forecast for 2030
Canopus BioPharma Incorporated Stock (CBIA) is expected to reach an average price of $1.7134 in 2030, with a high forecast of $2.2976 and a low forecast of $1.1292. This signifies an +1.71M% surge from the last price of $0.0001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.9478 | $1.1292 | $2.0436 | +1.95M% |
| February, 2030 | $1.4195 | $1.4195 | $1.766 | +1.42M% |
| March, 2030 | $1.9954 | $1.1577 | $2.0944 | +2.00M% |
| April, 2030 | $1.4544 | $1.4544 | $1.8104 | +1.45M% |
| May, 2030 | $2.043 | $1.1862 | $2.1452 | +2.04M% |
| June, 2030 | $1.4893 | $1.4893 | $1.8548 | +1.49M% |
| July, 2030 | $2.196 | $1.2147 | $2.196 | +2.20M% |
| August, 2030 | $1.5242 | $1.5242 | $2.0626 | +1.52M% |
| September, 2030 | $2.2468 | $1.2432 | $2.2468 | +2.25M% |
| October, 2030 | $1.7056 | $1.7056 | $2.1102 | +1.71M% |
| November, 2030 | $2.2976 | $1.2717 | $2.2976 | +2.30M% |
| December, 2030 | $1.7436 | $1.7436 | $2.1579 | +1.74M% |
3.12%
0.75%
Cap:
|
Volume (24h):